Bosnian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
osteoporosis/edema
Veza se sprema u međuspremnik
11 rezultati
Androgens and anabolic agents
Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
This application is a 371 of PCT/DE94/00316 filed Mar. 18, 1994.
BACKGROUND OF THE INVENTION
The invention relates to novel androgens and derivatives and analogs thereof, such as anabolic agents, and to methods of using them.
Male hormones, that is, androgens, such as testosterone and
.beta.- and .gamma.-diketones and .gamma.-hydroxyketones as WNT/ .beta.-catenin signaling pathway activators
Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to activators of one or more proteins in the Wnt pathway, including activators of one or more Wnt proteins, and compositions comprising the same. More particularly, it concerns the use of a .beta.-diketone, .gamma.-diketone
.beta.- and .gamma.-diketones and .gamma.-hydroxyketones as WNT/ .beta.-catenin signaling pathway activators
Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to activators of one or more proteins in the Wnt pathway, including activators of one or more Wnt proteins, and compositions comprising the same. More particularly, it concerns the use of a .beta.-diketone, .gamma.-diketone
.beta.- and .gamma.-diketones and .gamma.-hydroxyketones as WNT/.beta.-catenin signaling pathway activators
Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to activators of one or more proteins in the Wnt pathway, including activators of one or more Wnt proteins, and compositions comprising the same. More particularly, it concerns the use of a .beta.-diketone, .gamma.-diketone
.beta.- and .gamma.-diketones and .gamma.-hydroxyketones as Wnt/.beta.-catenin signaling pathway activators
Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to activators of one or more proteins in the Wnt pathway, including activators of one or more Wnt proteins, and compositions comprising the same. More particularly, it concerns the use of a .beta.-diketone, .gamma.-diketone
.beta.- and .gamma.-diketones and .gamma.-hydroxyketones as Wnt/.beta.-catenin signaling pathway activators
Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
BACKGROUND OF THE INVENTION
Field of the Invention
This invention relates to activators of one or more proteins in the Wnt pathway, including activators of one or more Wnt proteins, and compositions comprising the same. More particularly, it concerns the use of a .beta.-diketone, .gamma.-diketone or
.beta.- and .gamma.-diketones and .gamma.-hydroxyketones as Wnt/ .beta.-catenin signaling pathway activators
Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
BACKGROUND OF THE INVENTION
Field of the Invention
This invention relates to activators of one or more proteins in the Wnt pathway, including activators of one or more Wnt proteins, and compositions comprising the same. More particularly, it concerns the use of a .beta.-diketone, .gamma.-diketone or
.beta.- and .gamma.-diketones and .gamma.-hydroxyketones as WNT/.beta.-catenin signaling pathway activators
Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
BACKGROUND OF THE INVENTION
Field of the Invention
This invention relates to activators of one or more proteins in the Wnt pathway, including activators of one or more Wnt proteins, and compositions comprising the same. More particularly, it concerns the use of a .beta.-diketone, .gamma.-diketone or
.gamma.-diketones as Wnt/.beta.-catenin signaling pathway activators
Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
BACKGROUND
Technical Field
This disclosure relates to activators of one or more proteins in the Wnt pathway, including activators of one or more Wnt proteins, and compositions comprising the same. More particularly, it concerns the use of a .gamma.-diketones or salts or analogs thereof, in the
.gamma.-diketones as Wnt/.beta.-catenin signaling pathway activators
Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
BACKGROUND
Technical Field
This disclosure relates to activators of one or more proteins in the Wnt pathway, including activators of one or more Wnt proteins, and compositions comprising the same. More particularly, it concerns the use of a .gamma.-diketones or salts or analogs thereof, in the
.gamma.-diketones as WNT/.beta.-catenin signaling pathway activators
Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
BACKGROUND
Technical Field
This disclosure relates to activators of one or more proteins in the Wnt pathway, including activators of one or more Wnt proteins, and compositions comprising the same. More particularly, it concerns the use of a .gamma.-diketones or salts or analogs thereof, in the
Najkompletnija baza ljekovitog bilja potpomognuta naukom
- Radi na 55 jezika
- Biljni lijekovi potpomognuti naukom
- Prepoznavanje biljaka po slici
- Interaktivna GPS karta - označite bilje na lokaciji (uskoro)
- Pročitajte naučne publikacije povezane sa vašom pretragom
- Pretražite ljekovito bilje po učincima
- Organizirajte svoja interesovanja i budite u toku sa istraživanjem vijesti, kliničkim ispitivanjima i patentima
Upišite simptom ili bolest i pročitajte o biljkama koje bi mogle pomoći, unesite travu i pogledajte bolesti i simptome protiv kojih se koristi.
* Sve informacije temelje se na objavljenim naučnim istraživanjima
